Morphic Announces Appointment of Peter G. Linde, M.D., as Chief Medical Officer

Ads

You May Also Like

Innovation Pharmaceuticals Files Form 10-Q Quarterly Report

BEVERLY, Mass., Feb. 11, 2019 (GLOBE NEWSWIRE) -- Innovation Pharmaceuticals (OTCQB:IPIX) (“the Company”), a ...